Papaverine Hydrochloride (American Regent, Inc.)
Welcome to the PulseAid listing for the Papaverine Hydrochloride drug offered from American Regent, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | American Regent, Inc. |
NON-PROPRIETARY NAME: | Papaverine Hydrochloride |
SUBSTANCE NAME: | PAPAVERINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 1995-09-01 |
END MARKETING DATE: | 0000-00-00 |
Papaverine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Papaverine Hydrochloride from American Regent, Inc. |
LABELER NAME: | American Regent, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/mL) |
START MARKETING DATE: | 1995-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0517-4002_ac8f5e38-3e5b-4879-8d91-125a781e364f |
PRODUCT NDC: | 0517-4002 |
APPLICATION NUMBER: | |
Other PAPAVERINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: